Evaluation of health-related quality of life changes in an Australian rapid access chest pain clinic
- PMID: 39748242
- PMCID: PMC11697740
- DOI: 10.1186/s12913-024-12135-0
Evaluation of health-related quality of life changes in an Australian rapid access chest pain clinic
Abstract
Objective: To evaluate the impact of absolute cardiovascular risk counselling on quality-of-life indices within a chest pain clinic.
Data sources and study setting: Primary data was collected at the Royal Hobart Hospital, Australia, between 2014 and 2020.
Study design: Patients attending an Australian chest pain clinic were randomised into a prospective, open-label, blinded-endpoint study over a minimum 12-months follow-up.
Data collection / extraction methods: The SF-36 questionnaire was completed at baseline/follow-up and SF-6D multi-attribute utility instrument's health state utilities (HSU) were generated using SF-36 responses and the SF-6D's Australian tariff. SF-6D minimal important difference was 0.04 points. Absolute cardiovascular risk was also stratified into high/intermediate/low-risk categories for exploratory analysis of summary HSUs and dimensional scores. ANZCTR registration number 12617000615381 (registered 28/4/17).
Principal findings: Of n = 189 patients enrolled, HSUs were generated for 96% at baseline (intervention n = 93, usual care n = 88) and 61% at follow-up. There were no statistical differences in age, sex, absolute cardiovascular risk or mean HSU between groups at baseline. Summary HSUs improved more for the intervention group and the median between-group difference exceeded the minimal important difference threshold (intervention 0.16 utility points, control 0.10 utility points). For Intervention patients with high absolute risk (≥ 15%), HSU did not significantly change.
Conclusions: Absolute cardiovascular risk counselling in a chest pain clinic yielded clinically meaningful improvement in health-related quality of life.
Keywords: Absolute cardiac risk; Chest pain clinic; Cost-utility; Economic evaluation; Quality of life.
© 2025. Crown.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Tasmania’s Human Research Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the University of Tasmania’s Human Research Ethics Committee (approval number H0014029). Informed consent was obtained from all individual participants included in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Association between knee symptoms, change in knee symptoms over 6-9 years, and SF-6D health state utility among middle-aged Australians.Qual Life Res. 2021 Sep;30(9):2601-2613. doi: 10.1007/s11136-021-02859-5. Epub 2021 May 3. Qual Life Res. 2021. PMID: 33942204
-
Absolute risk assessment for guiding cardiovascular risk management in a chest pain clinic.Med J Aust. 2021 Apr;214(6):266-271. doi: 10.5694/mja2.50960. Epub 2021 Feb 23. Med J Aust. 2021. PMID: 33622026 Clinical Trial.
-
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities.Appl Health Econ Health Policy. 2024 Jul;22(4):583-598. doi: 10.1007/s40258-024-00879-z. Epub 2024 Mar 26. Appl Health Econ Health Policy. 2024. PMID: 38530626 Free PMC article.
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.Cochrane Database Syst Rev. 2018 Nov 6;11(11):CD006349. doi: 10.1002/14651858.CD006349.pub4. Cochrane Database Syst Rev. 2018. PMID: 30399208 Free PMC article.
References
-
- Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–25. - PubMed
-
- Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88. - PMC - PubMed
-
- Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014;171(3):368–76. - PubMed
-
- Nicolas M, Pestel L, Rivière S, Rachas A, Gastaldi-Menager C. Economic burden of cardiovascular diseases from 2012 to 2017 based on French national claim database. Eur J Public Health. 2019;29(Supplement_4):ckz187. 069.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical